Awards & Honors

Dr. Estol was recipient of the “Young Investigator's Award” to attend in 1989 the First International Stroke Society Congress in Kyoto with the manuscript: “Stroke after Liver Transplant: A Clinicopathological Study”.

He is the winner of the World Scientists Forum International Award “Eminent Scientist of the Year 2009” in the field “Scientists and Research on Stroke” from Argentina.

Dr. Estol's biography has been included in two books ("The Education of those who make a difference” and “The last 50 years of Argentine medicine and its protagonists”). He is also included in the “Who’sWho in Medicine and Healthcare”. In a survey conducted by the nationally distributed “Noticias” magazine, Dr. Estol was selected by his peers as one of the top 5 physicians in Argentina.

Publications

Dr. Estol published the first studies on the neurological complications of liver transplant. While working at the PUH in Pittsburgh, Dr. Estol had access to the largest series of transplanted patients in the world and initiated a project that ended with the first publications on the topic revealing the characteristics of encephalopathy, seizures, stroke, and central pontine myelinolysis in this population.

Dr. Estol reported significant beneficial effects of a new rehabilitation technique for back pain. The publication was reported for the first time at a press conference during the American Academy of Neurology meeting in the USA.

In addition to practicing medicine for 28 years, Dr. Estol has devoted a significant portion of his career to academic research and lecturing. Widely recognized as one of the world’s leading medical researchers in Cerebrovascular Diseases, Dr. Estol has published more than 50 original articles and editorials, 60 abstracts, 32 book chapters in international journals and books.

Teaching

With an ongoing active career in the USA, Dr. Estol decided to return to Argentina in 1991 and thus became the first formally trained physician in Cerebrovascular Disease in this country. He brought his experience in Transcranial Doppler, never performed before in Argentina and also trained local physicians in the specialty of Stroke.

Dr. Estol is regularly invited lecturer at international medical meetings (with greater than 120 conferences presented by invitation), was faculty with Dr. Louis Caplan at a Stroke course of the American Academy of Neurology for many years, was President and organizer of four international Stroke and Neurocritical Care meetings in Argentina, is one of the four Associate Editors of the International Journal of Stroke and Board member of various journals and medical societies.

Clinical Research

Dr. Estol published The Globalization of Clinical Trials (2003), which predicted a rapid outsourcing of drug trials outside of the United States and Europe because, among other things, developed countries had a progressively decreasing number of prospective, trial naïve patients to include in new drug studies.

In 2004, a major drug manufacturer requested that Dr. Estol serve as an international Steering Committee member and the National coordinator of the first large stroke trial conducted in Argentina. Sensing a real opportunity to continue his research activity in Argentina at a larger scale, he decided to formally set up a company to organize clinical trials.

Special Activities

Dr. Estol was invited by Pope John Paul II to participate in a conference on Brain Death at the Pontifical Academy of Sciences. Because no conclusions could be obtained, in 2006 Dr. Estol was asked by Pope Benedictus XVI to be the organizer of a second conference with the world authorities on the topic.

Dr. Estol was invited by the Pontifical Academy of Sciences to organize the meeting “Atherosclerosis: the 21st century epidemic” held in May 2010 at the Vatican. The goal is to increase awareness of heart and brain infarcts as the first and second causes of death across the world.

Dr. Estol was President of the Harvard Club in Argentina, a group of 300 former Harvard graduates (one of the largest Harvard groups outside the USA) formed largely by business (MBA's) and law (LLM's) graduates.